Бізнес · 20.07.20181 хв читання
Metered Dose Inhaler and Dry Powder Inhaler Drug Products-Quality Considerations; Draft Guidance for Industry; Reopening of the Comment Period
Локальний автоматичний переклад · Оригінальна мова джерела
Короткий зміст
The Food and Drug Administration (FDA, Agency, or we) is reopening the comment period for the "Metered Dose Inhaler and Dry Powder Inhaler Drug Products--Quality Considerations; Draft Guidance for Industry," published in the Federal Register of April 19, 2018. FDA is reopening the comment period to allow interested persons additional time to submit comments.